Fig. 9From: Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signallingCombined IN10018 and crizotinib induced ferroptosis. A Fluorescence pictures of ROS. B Quantitative analysis of ROS fluorescence intensity. C ROS detection by Flow cytometry. D Quantitative analysis of ROS. E Measurement of lipid peroxidation using C11-BODIPY. F Quantitative analysis of lipid peroxidation using C11-BODIPY. G MDA content assay. H, I, J GSH and GSSG concentrations were determined using a GSH assay kit. K Western blotting results for ferroptosis-related proteins. Significant levels: ns = not significant (P > 0.05), * P < 0.05, ** P < 0.01, and *** P < 0.001Back to article page